GreenLight XPS offers a safety profile equivalent to the current HPS technology.4
New, liquid-cooled fiber results in vaporization at twice the rate of HPS.1
FiberLife™ offers improved fiber reliability.
New TruCoag™ technology uses pulsating light to cauterize bleeding vessels.2
The Greenlight XPS™ provides up to 180 watts of lasing energy with the same safety profile as the PV and HPS systems.
Speed and Efficiency
Vaporization efficiency is significantly enhanced throughout the procedure with the MoXy™ liquid-cooled fiber, resulting in the removal of 2X more tissue over the same lasing time when compared to HPS.1
XPS with MoXy allows for the removal of a wider section of tissue without increasing the depth of tissue removal. Coagulation depth also remains the same.
MoXy's Active Cooling Cap™ technology utilizes saline flow to minimize fiber tip devitrification, which significantly reduces power degradation throughout the duration of the procedure.1
All surgical treatments have inherent and associated risks. The most common risks associated with Photoselective Vaporization of the Prostate (PVP) are hematuria, short term dysuria and UTI. See the GreenLight Operator's Manual or Surgical Guide CD for a complete list of possible risks and complications.
See the Instructions for Use and the Operator's Manual for the complete directions, contraindications, warnings, and risks associated with the device.
For more information, visit: http://www.amselabeling.com/